241 related articles for article (PubMed ID: 29158849)
1. Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.
Le Fèvre R; Durand-Dubief M; Chebbi I; Mandawala C; Lagroix F; Valet JP; Idbaih A; Adam C; Delattre JY; Schmitt C; Maake C; Guyot F; Alphandéry E
Theranostics; 2017; 7(18):4618-4631. PubMed ID: 29158849
[TBL] [Abstract][Full Text] [Related]
2. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.
Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I
Biomaterials; 2017 Oct; 141():210-222. PubMed ID: 28689117
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG-2 and GL-261 glioma cells in the presence of an alternating magnetic field.
Hamdous Y; Chebbi I; Mandawala C; Le Fèvre R; Guyot F; Seksek O; Alphandéry E
J Nanobiotechnology; 2017 Oct; 15(1):74. PubMed ID: 29041937
[TBL] [Abstract][Full Text] [Related]
4. Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors.
Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Gazeau F; Guyot F; Chebbi I
J Nanobiotechnology; 2019 Dec; 17(1):126. PubMed ID: 31870376
[TBL] [Abstract][Full Text] [Related]
5. Bio-synthesized iron oxide nanoparticles for cancer treatment.
Alphandéry E
Int J Pharm; 2020 Aug; 586():119472. PubMed ID: 32590095
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible and stable magnetosome minerals coated with poly-l-lysine, citric acid, oleic acid, and carboxy-methyl-dextran for application in the magnetic hyperthermia treatment of tumors.
Mandawala C; Chebbi I; Durand-Dubief M; Le Fèvre R; Hamdous Y; Guyot F; Alphandéry E
J Mater Chem B; 2017 Sep; 5(36):7644-7660. PubMed ID: 32264239
[TBL] [Abstract][Full Text] [Related]
7. Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.
Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I
J Control Release; 2017 Sep; 262():259-272. PubMed ID: 28713041
[TBL] [Abstract][Full Text] [Related]
8. Non-pyrogenic highly pure magnetosomes for efficient hyperthermia treatment of prostate cancer.
Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E
Appl Microbiol Biotechnol; 2023 Feb; 107(4):1159-1176. PubMed ID: 36633624
[TBL] [Abstract][Full Text] [Related]
9. Magnetosomes Extracted from
Mannucci S; Tambalo S; Conti G; Ghin L; Milanese A; Carboncino A; Nicolato E; Marinozzi MR; Benati D; Bassi R; Marzola P; Sbarbati A
Contrast Media Mol Imaging; 2018; 2018():2198703. PubMed ID: 30116160
[TBL] [Abstract][Full Text] [Related]
10. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia.
Alphandéry E; Guyot F; Chebbi I
Int J Pharm; 2012 Sep; 434(1-2):444-52. PubMed ID: 22698862
[TBL] [Abstract][Full Text] [Related]
11. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy.
Alphandéry E; Faure S; Seksek O; Guyot F; Chebbi I
ACS Nano; 2011 Aug; 5(8):6279-96. PubMed ID: 21732678
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
13. Multi-Stimuli-Responsive DOX Released from Magnetosome for Tumor Synergistic Theranostics.
Tsai MF; Lo YL; Huang YC; Yu CC; Wu YT; Su CH; Wang LF
Int J Nanomedicine; 2020; 15():8623-8639. PubMed ID: 33177822
[TBL] [Abstract][Full Text] [Related]
14. Natural Metallic Nanoparticles for Application in Nano-Oncology.
Alphandéry E
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575884
[TBL] [Abstract][Full Text] [Related]
15. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area.
Kossatz S; Ludwig R; Dähring H; Ettelt V; Rimkus G; Marciello M; Salas G; Patel V; Teran FJ; Hilger I
Pharm Res; 2014 Dec; 31(12):3274-88. PubMed ID: 24890197
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
17. Tuning of Magnetic Hyperthermia Response in the Systems Containing Magnetosomes.
Molcan M; Skumiel A; Timko M; Safarik I; Zolochevska K; Kopcansky P
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080372
[TBL] [Abstract][Full Text] [Related]
18. Applications of Magnetotactic Bacteria, Magnetosomes and Magnetosome Crystals in Biotechnology and Nanotechnology: Mini-Review.
Vargas G; Cypriano J; Correa T; Leão P; Bazylinski DA; Abreu F
Molecules; 2018 Sep; 23(10):. PubMed ID: 30249983
[TBL] [Abstract][Full Text] [Related]
19. Natural magnetic nanoparticle containing droplet for smart drug delivery and heat treatment.
Lee S; Ahn JH; Choi H; Seo JM; Cho D; Koo K
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():3541-4. PubMed ID: 26737057
[TBL] [Abstract][Full Text] [Related]
20. Smart Magnetotactic Bacteria Enable the Inhibition of Neuroblastoma under an Alternating Magnetic Field.
Chen C; Wang P; Chen H; Wang X; Halgamuge MN; Chen C; Song T
ACS Appl Mater Interfaces; 2022 Mar; 14(12):14049-14058. PubMed ID: 35311270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
